ADINITRO 2.6

ADINITRO 2.6 Trade Information

Minimum Order Quantity
100 Bottles

Delivery Time
5 Days

About ADINITRO 2.6

Nitroglycerin Controlled Release Tablets USP are a pharmaceutical formulation of nitroglycerin, designed to provide a sustained release of the drug over an extended period of time. Below is a summary of key information about this medication:

Generic Name:

Nitroglycerin (glyceryl trinitrate)

Dosage Form:

Controlled Release (also called Sustained Release or Extended Release) tablets, USP (United States Pharmacopeia standard)

Pharmacologic Class:

Organic nitrate; Vasodilator; Antianginal agent

Mechanism of Action:

Nitroglycerin works by releasing nitric oxide (NO) in vascular smooth muscle, which activates guanylate cyclase increases cyclic GMP leads to vasodilation.
This reduces myocardial oxygen demand by decreasing preload and afterload, and it improves blood flow to ischemic myocardial tissue.

Indications:

Prophylaxis of angina pectoris (chest pain) due to coronary artery disease
Not for immediate relief of acute angina attacks (short-acting sublingual forms are used for that)

Typical Dosage (example):

Common strengths: 2.5 mg, 6.5 mg, 9 mg (varies by manufacturer)
Usually taken twice daily, with 1012 hours nitrate-free interval to prevent tolerance.
Must be swallowed whole do not crush or chew.

*(Exact dosing should always be per the prescribing physician.)

Tell us about your requirement